The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Association of CYP 3 A 4 genotype with treatment-related leukemia
Open accessAbstract
Epipodophyllotoxins are associated with leukemias characterized by translocations of the MLL gene at chromosome band 11q23 and other translocations. Cytochrome P450 (CYP) 3A metabolizes epipodophyllotoxins and other chemotherapeutic agents. CYP3A metabolism generates epipodophyllotoxin catechol and quinone metabolites, which could damage DNA. There is a polymorphism in the 5′ promoter region of the CYP3A4 gene ( CYP3A4-V ) that might alter the metabolism of anticancer drugs. We examined 99 de novo and 30 treatment-related leukemias with a conformation-sensitive gel electrophoresis assay for the presence of the CYP3A4-V . In all treatment-related cases, there was prior exposure to one or more anticancer drugs metabolized by CYP3A. Nineteen of 99 de novo (19%) and 1 of 30 treatment-related (3%) leukemias carried the CYP3A4-V ( P = 0.026; Fisher’s Exact Test, FET). Nine of 42 de novo leukemias with MLL gene translocations (21%), and 0 of 22 treatment-related leukemias with MLL gene translocations carried the CYP3A4-V ( P = 0.016, FET). This relationship remained significant when 19 treatment-related leukemias with MLL gene translocations that followed epipodophyllotoxin exposure were compared with the same 42 de novo cases ( P = 0.026, FET). These data suggest that individuals with CYP3A4-W genotype may be at increased risk for treatment-related leukemia and that epipodophyllotoxin metabolism by CYP3A4 may contribute to the secondary cancer risk. The CYP3A4-W genotype may increase production of potentially DNA-damaging reactive intermediates. The variant may decrease production of the epipodophyllotoxin catechol metabolite, which is the precursor of the potentially DNA-damaging quinone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hayes, J. D., & Pulford, D. J. (1995) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239509083491 · Cited by 3,464
REPAIR OF OXIDATIVE DAMAGE TO DNA: Enzymology and Biology
Demple, B., & Harrison, L. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.004411 · Cited by 1,495
The Human Hepatic Cytochromes P450 Involved in Drug Metabolism
Wrighton, S. A., & Stevens, J. C. (1992) · Critical Reviews in Toxicology · doi:10.3109/10408449209145319 · Cited by 944
DNA glycosylases in the base excision repair of DNA
KROKAN, H. E., STANDAL, R., & SLUPPHAUG, G. (1997) · Biochemical Journal · doi:10.1042/bj3250001 · Cited by 859
Gu, Y., Nakamura, T., Alder, H., Prasad, R., Canaani, O., Cimino, G., Croce, C. M., & Canaani, E. (1992) · Cell · doi:10.1016/0092-8674(92)90603-a · Cited by 824
Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators
Cavalieri, E. L., Stack, D. E., Devanesan, P. D., Todorovic, R., Dwivedy, I., Higginbotham, S., Johansson, S. L., Patil, K. D., Gross, M. L., Gooden, J. K., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10937 · Cited by 727
Acute Myeloid Leukemia in Children Treated with Epipodophyllotoxins for Acute Lymphoblastic Leukemia
Pui, C.-H., Ribeiro, R. C., Hancock, M. L., Rivera, G. K., Evans, W. E., Raimondi, S. C., Head, D. R., Behm, F. G., Mahmoud, M. H., Sandlund, J. T., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112123252402 · Cited by 713
Homology-directed repair is a major double-strand break repair pathway in mammalian cells
Liang, F., Han, M., Romanienko, P. J., & Jasin, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5172 · Cited by 649
Chang, T. K. H., Weber, G. F., Crespi, C. L., & Waxman, D. J. (1993) · PubMed · Cited by 545
Second malignant neoplasms in children: an update from the Late Effects Study Group.
Meadows, A. T., Baum, E., Fossati-Bellani, F., Green, D., Jenkin, R. D., Marsden, B., Nesbit, M., Newton, W., Oberlin, O., & Sallan, S. G. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.4.532 · Cited by 481
Amirimani, B., Walker, A. H., Weber, B. L., & Rebbeck, T. R. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.18.1588 · Cited by 465
Self-citationSubstrates of human hepatic cytochrome P450 3A4
Li, A. (1995) · Toxicology · doi:10.1016/0300-483x(95)03155-9 · Cited by 367
Modification of Clinical Presentation of Prostate Tumors by a Novel Genetic Variant in CYP3A4
Rebbeck, T. R., Jaffe, J. M., Walker, A. H., Wein, A. J., & Malkowicz, S. B. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.16.1225 · Cited by 360
Self-citationLeukemia After Therapy With Alkylating Agents for Childhood Cancer2
Tucker, M. A., Meadows, A. T., Boice, J. D., Stovall, M., Oberlin, O., Stone, B. J., Birch, J., Voûte, P. A., Hoover, R. N., Fraumeni, J. F., et al. (1987) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/78.3.459 · Cited by 352
AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia
Nucifora, G., & Rowley, J. (1995) · Blood · doi:10.1182/blood.v86.1.1.bloodjournal8611 · Cited by 324
Cytochrome P4503A (CYP3A) metabolism: Prediction ofIn Vivo activity in humans
Wilkinson, G. R. (1996) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf02353475 · Cited by 311
Side, L., Taylor, B., Cayouette, M., Conner, E., Thompson, P., Luce, M., & Shannon, K. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706123362404 · Cited by 295
Mechanism of Action of Antitumor Drug Etoposide: A Review
van Maanen, J. M. S., Retel, J., de Vries, J., & Pinedo, H. M. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.19.1526 · Cited by 295
Chen, H. W., Sandler, D. P., Taylor, J. A., Bell, D. A., Shore, D. L., Liu, E., Bloomfield, C. D., Bloomfield, C. D., Sandler, D. P., & Liu, E. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90468-7 · Cited by 292
Raunio, H., Husgafvel-Pursiainen, K., Anttila, S., Hietanen, E., Hirvonen, A., & Pelkonen, O. (1995) · Gene · doi:10.1016/0378-1119(94)00448-2 · Cited by 269
Second cancers following pediatric Hodgkin's disease.
Wolden, S. L., Lamborn, K. R., Cleary, S. F., Tate, D. J., & Donaldson, S. S. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.536 · Cited by 268
Winick, N. J., McKenna, R. W., Shuster, J. J., Schneider, N. R., Borowitz, M. J., Bowman, W. P., Jacaruso, D., Kamen, B. A., & Buchanan, G. R. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.2.209 · Cited by 267
Self-citationRatain, M., Kaminer, L., Bitran, J., Larson, R., Le Beau, M., Skosey, C., Purl, S., Hoffman, P., Wade, J., & Vardiman, J. (1987) · Blood · doi:10.1182/blood.v70.5.1412.1412 · Cited by 258
HASHIMOTO, H., TOIDE, K., KITAMURA, R., FUJITA, M., TAGAWA, S., ITOH, S., & KAMATAKI, T. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18412.x · Cited by 209
When good enzymes go bad: Conversion of topoisomerase II to a cellular toxin by antineoplastic drugs
Corbett, A., & Osheroff, N. (1993) · Chemical Research in Toxicology · doi:10.1021/tx00035a001 · Cited by 201
Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia
Relling, M., Yanishevski, Y., Nemec, J., Evans, W., Boyett, J., Behm, F., & Pui, C.-H. (1998) · Leukemia · doi:10.1038/sj.leu.2400928 · Cited by 188
Variability in human cytochrome P450 paclitaxel metabolism.
Sonnichsen, D. S., Liu, Q., Schuetz, E. G., Schuetz, J. D., Pappo, A., & Relling, M. V. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12102-2 · Cited by 186
Quesnel, B., Kantarjian, H., Bjergaard, J. P., Brault, P., Estey, E., Lai, J. L., Tilly, H., Stoppa, A. M., Archimbaud, E., & Harousseau, J. L. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.12.2370 · Cited by 177
Studies on the Catalytic Mechanism of Five DNA Glycosylases
Sun, B., Latham, K. A., Dodson, M. L., & Lloyd, R. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.33.19501 · Cited by 159
Megonigal, M. D., Rappaport, E. F., Jones, D. H., Williams, T. M., Lovett, B. D., Kelly, K. M., Lerou, P. H., Moulton, T. A., Budarf, M. L., & Felix, C. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6413 · Cited by 157
Self-citationWalker, D., Flinois, J.-P., Monkman, S. C., Belloc, C., Boddy, A. V., Cholerton, S., Daly, A. K., Lind, M., Pearson Andrew, D. J., Beaune, P. H., et al. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90387-5 · Cited by 129
ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children
Felix, C., Hosler, M. R., Winick, N., Masterson, M., Wilson, A., & Lange, B. (1995) · Blood · doi:10.1182/blood.v85.11.3250.bloodjournal85113250 · Cited by 129
Self-citationMyeloid neoplasia in children treated for solid tumours
Pui, C.-H., Thompson, E., Wilimas, J. A., Bowman, L. C., Crist, W., Pratt, C. B., Pui, C., Raimondi, S., Head, D. R., Kun, L. E., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)91956-b · Cited by 111
Walker, A. H., Jaffe, J. M., Gunasegaram, S., Cummings, S. A., Huang, C., Chern, H. D., Olopade, O. I., Weber, B., & Rebbeck, T. R. (1998) · PubMed · Cited by 110
Self-citationAbasic Sites Stimulate Double-stranded DNA Cleavage Mediated by Topoisomerase II
Kingma, P. S., Corbett, A. H., Burcham, P. C., Marnett, L. J., & Osheroff, N. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.21441 · Cited by 108
Singer, B. A., & Hang, B. (1997) · Chemical Research in Toxicology · doi:10.1021/tx970011e · Cited by 106
Apurinic Sites Are Position-specific Topoisomerase II Poisons
Kingma, P. S., & Osheroff, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.1148 · Cited by 100
Maris, J. M., Wiersma, S. R., Mahgoub, N., Thompson, P., Geyer, R. J., Hurwitz, C. G., Lange, B. J., & Shannon, K. (1997) · PubMed · Cited by 89
Self-citationThe p53 gene in pediatric therapy-related leukemia and myelodysplasia
Felix, C., Hosler, M. R., Provisor, D., Salhany, K., Sexsmith, E., Slater, D., Cheung, N., Winick, N., Strauss, E., Heyn, R. M., et al. (1996) · Blood · doi:10.1182/blood.v87.10.4376.bloodjournal87104376 · Cited by 80
Self-citationRadiotherapy- and chemotherapy-induced myelodysplasia and acute myeloid leukemia. A review
Pedersen-Bjergaard, J. (1992) · Leukemia Research · doi:10.1016/0145-2126(92)90102-d · Cited by 68
Spontaneous DNA Damage Stimulates Topoisomerase II-mediated DNA Cleavage
Kingma, P. S., & Osheroff, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.7488 · Cited by 62
Changing patterns of care in the management of anemia.
Henry, D. H. (1992) · PubMed · Cited by 57
Second Cancer Following Chemotherapy and Radiotherapy: An epidemiological perspective
Kaldor, J. M. (1990) · Acta Oncologica · doi:10.3109/02841869009090070 · Cited by 32
Mans, D. R. A., Retèl, J., van Maanen, J., Lafleur, M. V. M., Schaik, M. A. V., Pinedo, H. M., & Lankelma, J. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.228 · Cited by 31
Cited by
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
Evans, W. E., & Relling, M. V. (1999) · Science · doi:10.1126/science.286.5439.487 · Cited by 2,475
Acute Lymphoblastic Leukemia in Children
Hunger, S. P., & Mullighan, C. G. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1400972 · Cited by 2,204
Kuehl, P., Zhang, J., Lin, Y., Lamba, J., Assem, M., Schuetz, J., Watkins, P. B., Daly, A., Wrighton, S. A., Hall, S. D., et al. (2001) · Nature Genetics · doi:10.1038/86882 · Cited by 2,162
Genetic contribution to variable human CYP3A-mediated metabolism
Lamba, J. K., Lin, Y. S., Schuetz, E. G., & Thummel, K. E. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00066-2 · Cited by 990
Polymorphism of human cytochrome P450 enzymes and its clinical impact
Zhou, S.-F., Liu, J.-P., & Chowbay, B. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530902843483 · Cited by 826
Metadata
- Authors
- Felix, C. A., Walker, A. H., Lange, B. J., Williams, T. M., Winick, N. J., Cheung, N.-K. V., Lovett, B. D., Nowell, P. C., Blair, I. A., & Rebbeck, T. R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1998-10-27
- Volume
- 95
- Issue
- 22
- Pages
- 13176-13181
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2072467180
- Cited by
- 310
- References
- 44
- FWCI
- 19.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.